SLOUGH, United Kingdom and
RICHMOND, Va., Nov. 6, 2018
/PRNewswire/ -- Indivior PLC (LON: INDV) today announced the
following upcoming investor events:
Stifel 2018 Healthcare Conference, New York City:
On Tuesday, November 13th from
9:30 a.m. to 10:10 a.m. (local time)
Shaun Thaxter, CEO, and Mark Crossley, CFO, will conduct a fireside chat
with Max Hermann, Stifel Healthcare
Analyst.
Indivior 2018 Capital Markets Day, New York City:
On Wednesday, December 5th from
9:00 a.m. to 12:30 p.m. (local time),
Indivior senior management will review and present the Company's
key business lines. Attendance for this event will require
pre-registration, as space is limited. To register, please send an
e-mail to jason.thompson@indivior.com.
A live webcast of both events, including any presentations, will
be available on the "Investors" section of the company's website at
www.indivior.com.
About Indivior
Indivior is a global specialty
pharmaceutical company with a 20-year legacy of leadership in
patient advocacy and health policy while providing education on
evidence-based treatment models that have revolutionized modern
addiction treatment. The name is the fusion of the words individual
and endeavor, and the tagline "Focus on you" makes the Company's
commitment clear. Indivior is dedicated to transforming addiction
from a global human crisis to a recognized and treated chronic
disease. Building on its global portfolio of opioid dependence
treatments, Indivior has a strong pipeline of product candidates
designed to both expand on its heritage in this category and
address other chronic conditions and co-occurring disorders of
addiction, including alcohol use disorder and schizophrenia.
Headquartered in the United States
in Richmond, VA, Indivior employs
more than 900 individuals globally and its portfolio of products is
available in over 40 countries worldwide. Visit www.indivior.com to
learn more.
View original
content:http://www.prnewswire.com/news-releases/indivior-announces-upcoming-investor-events-300744207.html
SOURCE Indivior PLC